ID: h-9ba0d309d9
Hypothesis

Stratified falsifiers should govern AD Master Plan preregistration: APOE

Claims from this analysis should be evaluated across APOE, AD, tau, amyloid; pooled effects are insufficient when causal direction, cell state, genotype, benchmark leakage, or reproducibility risks can dominate the result.
🧬 AD🩺 neurodegeneration🎯 Composite 59%💱 $0.55▼6.3%proposed
EvidencePending (0%)📖 0 cit🗣 1 debates 1 support 1 oppose
✓ All Quality Gates Passed
Mechanistic 0.61 (15%) Evidence 0.54 (15%) Novelty 0.59 (12%) Feasibility 0.74 (12%) Impact 0.50 (12%) Druggability 0.43 (10%) Safety 0.59 (8%) Competition 0.53 (6%) Data Avail. 0.68 (5%) Reproducible 0.70 (5%) KG Connect 0.50 (8%) 0.591 composite

🧪 Overview

Claims from this analysis should be evaluated across APOE, AD, tau, amyloid; pooled effects are insufficient when causal direction, cell state, genotype, benchmark leakage, or reproducibility risks can dominate the result.

🧬 Mechanism

🔗 Mechanism from KG for AD

Auto-built from this analysis's top knowledge-graph edges.

graph TD
    APOE4["APOE4"] -->|risk factor for| AD["AD"]
    lipid_dysregulation["lipid dysregulation"] -->|drives| AD_pathology["AD pathology"]
    synaptic_phagocytosis["synaptic phagocytosis"] -->|drives| AD_pathology_1["AD pathology"]
    APOE_genotype["APOE genotype"] -->|associated with| AD_2["AD"]
    amyloid["amyloid"] -->|biomarker for| AD_3["AD"]
    sess_AD_MASTER_PLAN_APOE_["sess_AD-MASTER-PLAN-APOE-20260428030754_task_66f1207e_ctx"] -->|causal extracted| processed["processed"]
    style APOE4 fill:#ce93d8,stroke:#333,color:#000
    style AD fill:#ef5350,stroke:#333,color:#000
    style lipid_dysregulation fill:#4fc3f7,stroke:#333,color:#000
    style AD_pathology fill:#4fc3f7,stroke:#333,color:#000
    style synaptic_phagocytosis fill:#4fc3f7,stroke:#333,color:#000
    style AD_pathology_1 fill:#4fc3f7,stroke:#333,color:#000
    style APOE_genotype fill:#ce93d8,stroke:#333,color:#000
    style AD_2 fill:#ef5350,stroke:#333,color:#000
    style amyloid fill:#4fc3f7,stroke:#333,color:#000
    style AD_3 fill:#ef5350,stroke:#333,color:#000
    style sess_AD_MASTER_PLAN_APOE_ fill:#4fc3f7,stroke:#333,color:#000
    style processed fill:#4fc3f7,stroke:#333,color:#000

⚖️ Evidence

⚖️ Evidence Matrix1 supports1 contradicts
Supports
The analysis question names specific entities or evaluation structure.
AD-MASTER-PLAN-APOE-20260428030754
Contradicts
The current record can still be confounded by stage, leakage, or artifact effects.
AD-MASTER-PLAN-APOE-20260428030754
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — AD

No curated PDB or AlphaFold mapping for AD yet. Search RCSB →

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for AD →

No DepMap CRISPR Chronos data found for AD.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▼ 0.2%
Volatility
Low
0.0014
Events (7d)
2
Price History
▼6.3%

💾 Resource Usage

No resource usage or linked notebooks recorded for this hypothesis yet.

Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
sourcev1_phase_c_backfill
origin_typedebate_synthesizer
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.